These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 16243221)
21. Long-term safety and efficacy in patients with uncontrolled partial-onset seizures treated with adjunctive lacosamide: results from a Phase III open-label extension trial. Husain A; Chung S; Faught E; Isojarvi J; McShea C; Doty P Epilepsia; 2012 Mar; 53(3):521-8. PubMed ID: 22372628 [TBL] [Abstract][Full Text] [Related]
22. Perampanel, a selective, noncompetitive α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor antagonist, as adjunctive therapy for refractory partial-onset seizures: interim results from phase III, extension study 307. Krauss GL; Perucca E; Ben-Menachem E; Kwan P; Shih JJ; Squillacote D; Yang H; Gee M; Zhu J; Laurenza A Epilepsia; 2013 Jan; 54(1):126-34. PubMed ID: 22905878 [TBL] [Abstract][Full Text] [Related]
23. Oxcarbazepine in the treatment of epilepsy. Glauser TA Pharmacotherapy; 2001 Aug; 21(8):904-19. PubMed ID: 11718497 [TBL] [Abstract][Full Text] [Related]
24. Adjunctive levetiracetam in infants and young children with refractory partial-onset seizures. Piña-Garza JE; Nordli DR; Rating D; Yang H; Schiemann-Delgado J; Duncan B; Epilepsia; 2009 May; 50(5):1141-9. PubMed ID: 19243423 [TBL] [Abstract][Full Text] [Related]
25. Clinical feasibility of immediate overnight switching from slow-release carbamazepine to oxcarbazepine in Korean patients with refractory partial epilepsy. Lee SA; Heo K; Kim WJ; Song HK; Kim SE; Kim SH; No SK; Lee BI Seizure; 2010 Jul; 19(6):356-8. PubMed ID: 20538492 [TBL] [Abstract][Full Text] [Related]
26. Long-term safety and tolerability of oxcarbazepine in painful diabetic neuropathy. Beydoun S; Alarcón F; Mangat S; Wan Y Acta Neurol Scand; 2007 Apr; 115(4):284-8. PubMed ID: 17286624 [TBL] [Abstract][Full Text] [Related]
27. Improved quality of life in patients with partial seizures after conversion to oxcarbazepine monotherapy. Sachdeo RC; Gates JR; Bazil CW; Barkley GL; Tatum W; D'Souza J; McCague K Epilepsy Behav; 2006 Nov; 9(3):457-63. PubMed ID: 16934534 [TBL] [Abstract][Full Text] [Related]
32. Long-term safety and tolerability of oxcarbazepine in children: a review of clinical experience. Bourgeois BF; D'Souza J Epilepsy Behav; 2005 Nov; 7(3):375-82. PubMed ID: 16176888 [TBL] [Abstract][Full Text] [Related]
33. Response to carbamazepine in children with newly diagnosed partial onset epilepsy. Holland KD; Glauser TA Neurology; 2007 Aug; 69(6):596-9. PubMed ID: 17679679 [TBL] [Abstract][Full Text] [Related]
34. Oxcarbazepine in the treatment of childhood epilepsy. Serdaroglu G; Kurul S; Tutuncuoglu S; Dirik E; Sarioglu B Pediatr Neurol; 2003 Jan; 28(1):37-41. PubMed ID: 12657418 [TBL] [Abstract][Full Text] [Related]
35. Drug monitoring of lamotrigine and oxcarbazepine combination during pregnancy. Wegner I; Edelbroek P; de Haan GJ; Lindhout D; Sander JW Epilepsia; 2010 Dec; 51(12):2500-2. PubMed ID: 21204816 [TBL] [Abstract][Full Text] [Related]
36. Myoclonic-astatic epilepsy in a child with Sturge-Weber syndrome. Ewen JB; Comi AM; Kossoff EH Pediatr Neurol; 2007 Feb; 36(2):115-7. PubMed ID: 17275664 [TBL] [Abstract][Full Text] [Related]
37. Relative bioavailability, metabolism and tolerability of rectally administered oxcarbazepine suspension. Clemens PL; Cloyd JC; Kriel RL; Remmel RP Clin Drug Investig; 2007; 27(4):243-50. PubMed ID: 17358096 [TBL] [Abstract][Full Text] [Related]
38. Bioequivalence of oxcarbazepine oral suspension vs. film-coated tablet in healthy Chinese male subjects. Souppart C; Yin Q; Merz M; Hu P; Jiang J; Appel-Dingemanse S Int J Clin Pharmacol Ther; 2008 Oct; 46(10):538-44. PubMed ID: 18826868 [TBL] [Abstract][Full Text] [Related]
39. Oxcarbazepine for epilepsy--a useful new choice? Drug Ther Bull; 2002 Jun; 40(6):46-8. PubMed ID: 12143266 [TBL] [Abstract][Full Text] [Related]